anmelden
SMI
14.223,90
PKT
+51,19
PKT
+0,36
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.01.20 | Novartis Neutral | Credit Suisse Group | |
| 30.01.20 | Roche overweight | Barclays Capital | |
| 30.01.20 | Roche buy | UBS AG | |
| 30.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 30.01.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 30.01.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 29.01.20 | UBS Underweight | Barclays Capital | |
| 29.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 29.01.20 | Novartis Neutral | UBS AG | |
| 29.01.20 | Novartis Hold | Kepler Cheuvreux | |
| 29.01.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.01.20 | UBS buy | Goldman Sachs Group Inc. | |
| 28.01.20 | UBS Outperform | Credit Suisse Group | |
| 28.01.20 | Nestlé kaufen | Kepler Cheuvreux | |
| 28.01.20 | Givaudan buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 27.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 27.01.20 | UBS Hold | Deutsche Bank AG | |
| 27.01.20 | Givaudan Hold | Deutsche Bank AG | |
| 27.01.20 | Roche buy | Deutsche Bank AG | |
| 24.01.20 | UBS Sector Perform | RBC Capital Markets | |
| 24.01.20 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 24.01.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 24.01.20 | Givaudan buy | UBS AG | |
| 24.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 24.01.20 | Givaudan add | Baader Bank | |
| 24.01.20 | Givaudan Underperform | Bernstein Research | |
| 24.01.20 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 24.01.20 | Swiss Re overweight | Barclays Capital | |
| 24.01.20 | Nestlé Hold | Jefferies & Company Inc. | |
| 23.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 23.01.20 | UBS buy | Kepler Cheuvreux | |
| 23.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 22.01.20 | UBS Outperform | Credit Suisse Group | |
| 22.01.20 | UBS Sector Perform | RBC Capital Markets | |
| 22.01.20 | Swiss Re Outperform | Credit Suisse Group | |
| 22.01.20 | Holcim Neutral | UBS AG | |
| 22.01.20 | Roche buy | Jefferies & Company Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.